In this presentation, Ildiko Lingvay, MD, discusses the use of SGLT2 Inhibitors for primary care physicians.
Created by
Related Presenters
Professor of Medicine, Division of Endocrinology and Department of Population & Data Sciences
Dr. Lingvay is a clinical investigator in the field of diabetes, obesity, and associated metabolic complications. She leads an active clinical research program in the Division of Endocrinology at University of Texas Southwestern Medical ...